View drug registration information details.
Items | Registration information |
ID | 318 |
No | 318 |
Brand Name | HOVASC 5 MG |
Ingredients | AMLODIPINE BESILATE 5 MG |
Dosage Form | TABLET |
Primary Packaging | BLISTERPACK |
Storage | STORE BELOW 25"C |
Shelf Life | 3 YEARS |
Pack Size | 10 TABLETS/BLISTER, 100 TABLETS/BOX |
Dispensing Category | Prescription only |
ATC Classification | C02DE12 |
Pharmaceutical Class | ANTIHYPERTENSIVES |
Indications | AMLODIPINE IS INDICATED FOR THE FIRST LINE TREATMENT OF HYPERTENSION AND CAN BE USED AS THE SOLE AGENT TO CONTROL BLOOD PRESSURE IN THE MAJORITY OF PATIENTS NOT ADEQUATELY CONTROLLED ON A SINGLE ANTIHYPERTENSIVE AGENT MAY BENEFIT FROM THE ADDITION OF AMLO |
Contraindications | AMLODIPINE IS CONTRAINDICATED IN PATIENTS WITH KNOWN HYPERSENSITIVITY TO DIHYDROPYRIDINE DERIVATIVES. |
Side Effects | FLUSHING, FATIGUE, EDEMA, NAUSEA, DIZZINESS |
Unit Price | - |
EDL |
Yes |
Description | OBLONG, WHITE TO OFF WHITE UNCOATED TABLET, BEVEL EDGED, SHALLOW CONVEX WITH BREAK BAR ON ONE FACE AND "HOVID"EMBOSSED ON ANOTHER FACE. |
Note | |
License Owner | BMS PHARMA SOLE CO.,LTD |
Manufacturer | HOVID BHD |
Country | MALAYSIA |
Import Registration No | MAL 07090911 AZ |
Import Registration Date | 2017-09-29 |
Activity | CERTIFICATE RELEASED |
Applied Date | 2023-03-16 |
FDD Registration No | 07 I 4167/16 |
FDD Registration Date | 2023-06-07 |
Expiry Date | 2026-06-06 |
Back to drug list
|